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ABSTRACT
OBJECTIVE: To assess the prevalence of multimorbidity among Brazilian adults and its 
association with socioeconomic indicators. 
METHODS: Cross-sectional study that used data from the Pesquisa Nacional Sobre Acesso, 
Utilização e Promoção do Uso Racional de Medicamentos no Brasil (PNAUM – Brazilian National 
Survey on Access, Use and Promotion of Rational Use of Medicines), carried out between 2013 
and 2014. The definition of multimorbidity was the coexistence, in a single individual, of two 
or more chronic diseases, measured through a list of 14 morbidities (self-reported medical 
diagnosis throughout life). Economic status and educational level were the socioeconomic 
indicators used, being the inequalities assessed through the Slope Index of Inequality (SII) and 
the Concentration Index, stratified by gender.  
RESULTS: The study comprehended 23,329 adults (52.8% of which were women), with an average 
age of 37.9 years. Hypertension and high cholesterol levels were the most prevalent conditions. 
The prevalence of multimorbidity was of 10.9% (95%CI 10.1–11.7) representing nearly 11 million 
individuals in Brazil, of which 14.5% (95%CI 13.5–15.4) were women and 6.8% (95%CI 5.9–7.8) 
were men. The occurrence of multimorbidity was similar according to the socioeconomic 
indicators. In the inequality analysis, we observed absolute and relative differences in men 
with a higher purchasing power (SII = 3.7; 95%CI 0.3–7.0) and higher educational level (CIX = 7.1; 
95%CI 0.9–14.7), respectively. 
CONCLUSIONS: The frequency of comorbidities in Brazilian adults is high, especially in 
absolute terms. We only observed socioeconomic inequalities in multimorbidities among men. 
DESCRIPTORS: Adult. Socioeconomic Factors. Multimorbidity. Cross-Sectional Studies.
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INTRODUCTION
The definition of multimorbidity is the coexistence of two or more chronic diseases in a 
single individual1.It has connections to a higher mortality risk; to a reduction in functional 
capacity, in cognitive skills and in quality of life; to the increase in usage of healthcare 
services and the amount of drugs prescribed per patient2.
The multimorbidity presents direct relation with the age increment3,4. In this sense, we 
observed a greater concentration of higher educational levels among the older adults (aged 
60 years and older), with more scarce evidence among the younger population2,5,6.
A cohort study conducted in Australia emphasized the importance of observing 
multimorbidity in the younger ranges of the population. The study found that 4.4% 
(95%CI 3.4–5.7) of individuals aged between 20 and 39 years old had two or more chronic 
diseases, while in the population aged between 40 and 59 years old, the figure was of 15,0% 
(95%CI 13.1–17.2).7 In Brazil, the multimorbidity is present in nearly one in every five and 
one in every 10 adults (≥ 18 years old) for ≥ 2 e ≥ 3, respectively.4 A study conducted by 
Carvalho and contributors8 showed that 5.6% of participants aged between 18 and 29 years 
old presented multimorbidity; this figure was of 12.3% for ages between 30 and 39 years old 
and of 23.9% between 40 and 49. Likewise, another study conducted in the country showed 
that between 18 and 24 years old, the percentage of multimorbidity was of 5.5%; between 
24 and 44 years old, of 13.2%, and between 45 and 64 years old, of 36.2%.9
The prevalence of multimorbidity is higher among women, according to research projects 
conducted in Brazil4,5,8, in Germany2 and in Canada10. In addition, longitudinal analyses 
and a systematic review also observed such pattern. 
Another factor usually associated with multimorbidity is the socioeconomic status – 
we observed a variation in the problem occurrence according to the socioeconomic 
characteristics of the population, depending on the socioeconomic indicator used. Certain 
studies evidenced an increase in multimorbidity as the educational level decreased2,4,5,8,12.
Systematic review and meta-analysis conducted in studies published up until 2014 evidenced 
that a low educational level was associated with a chance 1.64 (95%CI 1.41–1.91) times higher 
of multimorbidity in comparison to individuals with a higher educational level13. Compared 
with other socioeconomic indicators, especially income, the relation is less evident. 
The results found in the literature regarding an association between multimorbidity and 
socioeconomic level are often heterogeneous. This may be due to the methodology used in the 
studies to assess the socioeconomic level, given that the literature describes several methods 
to assess it. Some of these are: assessment of household income13, educational level14, literacy, 
socioeconomic status, employment status, property ownership and even self-perception of 
poverty13. Of these methods, the educational level seems to be the indicator most strongly 
associated with multimorbidity. However, the literature on the subject presents analyses of 
inequalities considering the difference between the ends of this socioeconomic indicator. 
To assess inequalities, more complex methods are under use. Among them, we call 
attention to the indexes that assess inequalities considering the entire stratification of the 
socioeconomic indicators, in addition to providing summary measures of the absolute and 
relative differences, which are methods more suited to the measurement of the inequalities 
and that we will use in the assessments proposed by this study. 
In a study conducted with civil servants of a higher education institution in Rio de Janeiro, 
Brazil, Jantsch and contributors12 found inverse relationship between educational level 
and multimorbidity, presenting three times more (RII = 2.97; 95%CI 1.94–4.54) occurrences 
between the ends of educational level. The indicator of absolute inequality (Slope Index of 
Inequality – SII) showed prevalence of multimorbidity 22 percentage points higher among 
women with lower educational levels than among those with higher educational levels. 
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The objective of this study was to assess the prevalence of multimorbidity and its association 
with socioeconomic indicators among Brazilian adults, considering the increase in 
multimorbidity among the younger age brackets of the population, the variation and the 
heterogeneous results according the socioeconomic levels of the individuals, the importance 
of assessing inequalities in health, and the scarcity of national studies. The hypothesis is 
that women with lower educational levels will present more multimorbidity, in terms of 
both absolute and relative inequalities.
METHODS
Cross-sectional study, population-based, conducted on data originated from the population 
survey component of the Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso 
Racional de Medicamentos no Brasil (PNAUM – Brazilian National Survey on Access, Use 
and Promotion of Rational Use of Medicines), conducted between 2013 and 2014.
The PNAUM interviewed 41,333 people in households of the urban areas in 245 
municipalities of 26 states and the Federal District and had the goal of assessing the 
population’s access to medicines, its use, rational use, sources of supply, and most prevalent 
morbidities that cause the use of medicines. After adjusting geopolitics region, gender and 
age, the sample represented nearly 171 million of people residing in the urban area of the 
country at the time. The sample draw considered three stages per cluster: municipality 
(primary sampling unit), census tract and household. The questionnaire, developed and 
tested by researchers from seven Brazilian universities, was conducted in a visit of the 
researcher to the interviewees’ household. The questions asked covered, among several 
subjects, the current use of medicines to treat chronic diseases, and are available on the 
survey’s websitea. The survey used tablets for data collection, which were loaded into a 
software especially developed to the PNAUM. Further methodological detail is available 
on an article published by Sotero et al.16 
In this analysis, we considered adult individuals aged between 20 and 59 years old. 
The dependent variable was the presence of multimorbidity, characterized by the 
simultaneous occurrence of two or more chronic diseases17, measured through the report 
of medical diagnosis of the following morbidities: hypertension, high cholesterol level, 
depression, arthritis or rheumatism, diabetes, chronic pulmonary disease, coronary 
heart diseases, thyroid disorders, digestive disorder, stroke, neurological disorder, 
cancer, kidneys disease and other chronic diseases (for over six months). To other 
diseases, the survey kept only the conditions considered chronic, excluding morbidities 
and/or non-chronic conditions described by the interviewees (such as alcoholism and 
amygdalate). If the interviewee referred, in the question about other chronic diseases, 
any morbidity already inquired, the previous response was reviewed, accounting the 
morbidity only once. 
The main exposure variable was socioeconomic status, assessed through two indicators: 
1) economic status based on the property ownership (socioeconomic stratification in 
Brazil – ABEP 2013b), categorized in quintiles – due to the high proportion of middle-class 
individuals; 2) educational level of the interviewee, categorized in total years of education 
(none, 1–8, 9–11, ≥ 12). Other variables were gender (male/female) and age in years (20–29, 
30–39, 40–49, 50–59). In the descriptive table of the sample, the socioeconomic status was 
presented as the status proposed by the indicator (A/B, C, D/E). 
The prevalence estimates (%) of multimorbidity and the respective confidence intervals (95%) 
were calculated for the gender, age bracket, educational level and socioeconomic status. 
We based the assessment of the socioeconomic inequalities related to multimorbidity on 
the analysis of two indexes: 1) Slope Index of Inequality (SII), or absolute index of inequality; 
2) Concentration Index of Inequality (CIX), or concentration index. The SII is used for 
stratification variables that are ordinal (such as socioeconomic status and educational 
a Pesquisa Nacional sobre 
Acesso, Utilização e 
Promoção do Uso Racional de 
Medicamentos no Brasil. 2013. 
[cited 2020 Apr 20]. Available 
from: http://www.ufrgs.br/pnaum.
b Associação Brasileira de 
Empresas de Pesquisa. Critério 
Brasil de Classificação 
Econômica. São Paulo: Abep, 
2013.
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level, used in the present analysis), representing the absolute difference in a health indicator 
among the most-advantaged and most-disadvantaged individuals and considering the 
entire distribution of the stratum. It also indicates the slope of the resulting regression line, 
being the absolute difference in the adjusted value of the health indicator between the two 
extremes of the socioeconomic indicator classification. The CIX considers all stratification 
categories, where 0 equals to equality18. In both indexes, we used the -100 to 100 scale to 
express the results. 
We stratified our analysis by gender, and we weighted the results considering the study 
sampling design. We presented supplementary analyses for each of the country’s geopolitical 
regions (North, Northeast, Midwest, Southeast and South). We considered the associations 
statistically significant when the 95%CI limits did not include the null value (SII or CIX 
equals to 0). We conducted all analyses using the Stata/SE 12.0 software. 
The PNAUM was submitted to the National Commission for Ethics in Research (CONEP) under 
the Certificate of Presentation for Ethical Appreciation (CAAE) no. 18947013.6.0000.0008, 
and was approved under the report no. 398.131/2013, to be carried out at national level. The 
participants received information about the survey and signed an informed consent form 
before the interview. 
RESULTS
The study comprehended data from 23,329 adults (52.8% of which were women) that, when 
extrapolated to the target-population, represent nearly 96 million adults living in the urban 
area of Brazil. The total response rate varied from 43.9% of men aged between 20 and 39 
years old to 53.4% of women aged between 20 and 39 years old. The sample mean age was 
of 37.9 years (38.3 years among women, 37.5 years among men).
In both genders, the age bracket ranging from 20 to 29 years and people with 1 to 8 
educational years prevailed. The results among those who never attended school and those 
with 12 or over school years were also similar in both genders. Regarding the economic 
status, 24.8% felt under A/B classes and 20.1% felt under D/E classes (Table 1). 
Regarding morbidities, we observed that hypertension and high cholesterol levels were 
the most prevalent diseases in both genders. Stomach disease, stroke, other neurological 
disorders, cancer, kidney diseases and other chronic diseases presented prevalence lower 
than 1.5% for both genders, and the last five, out of the entire set, had a lower prevalence 
among women than among men (Table 1). 
The presence of multimorbidity was 10.9% (95%CI 10.1–11.7), 14.5% (95%CI 13.5–15.4) among 
women and 6.8% (95%CI 5.9–7.8) among men (Table 1). According to the age brackets, the 
prevalence varied from 2.7% (95%CI 2.2–4.4) among adults aged 20 to 29 years old to 26.9% 
(95%CI 25.2–28.7) among those aged 50 to 59 years old. 
The prevalence of multimorbidity was similar regarding the socioeconomic indicators, 
being a percentage higher among adults with 9 to 11 schooling years and belonging to the 
greatest quintile of property ownership (Figure 1). We did not find results different than 
those of the general sample when conducting additional analyses stratified by age. 
In the analyses of inequality, we observed a statistically significant difference among men. 
We found absolute and relative inequality, with the outcome concentrated among men with 
greater purchasing power (SI = 3.6 and SII = 9.5), and relative inequality, with the outcome 
concentrated among men with more school years (CIX = 7.1) (Table 2). 
We conducted supplementary analyses to assess the inequality of multimorbidity, stratified 
by gender, across the five geopolitical regions of Brazil (Table 2). We observed statistically 
significant difference, considering the relative and absolute indexes of inequality, among 
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Table 1. Sociodemographic characteristics, chronic diseases and multimorbidity per gender, among 









Educational level (in years of 
schooling)
Never attended school 14.6 14.9
1–8 42.8 44.2
9–11 31.3 29.9







High cholesterol levels 8.5 5.6
Depression 7.9 2.4
Arthritis or rheumatism 6.0 2.2
Diabetes 4.6 3.2
Chronic pulmonar disease 4.2 1.9
Coronary heart diseases 3.3 2.2
Thyroid disorders 1.9 0.2
Digestive disorder 1.0 0.7
Stroke 0.7 0.8
Neurological disorder 0.7 1.0
Cancer 0.3 0.0
Kidney disease 0.3 0.3
Another chronic disease 0.2 0.1
Multimorbidity ≥ 2 diseases 14.5 6.8
a Rates adjusted by sampling weight and by post-stratification according to age and gender. 
b Diseases presented in ascending order of occurrence in women. 
Table 2. Multimorbidity inequalities analysis, stratified by gender and geopolitical regions. PNAUM, Brazil, 2014. 
Regions Indexes
Educational level Socioeconomic status
Women Men Women Men
North
SII (95%CI) 1.4 (-2.2 to 5.0) -(-5.6 to 4.4) -1.1 (-5.7 to 3.6) 2.8 (-2.4 to 8.0)
CIX (95%CI) 1.4 (-6.3 to 9.1) 1.8 (-16.2 to 19.8) -1.1 (-10.3 to 8.0) 8.8 (-7.5 to 25.2)
Northeast
SII (95%CI) -2.3 (-7.6 to 3.0) 5.0 (-0.3 to 10.3) 0.9 (-3.6 to 5.4) 0.7 (-4.4 to 5.8)
CIX (95%CI) -2.5 (-9.2 to 4.1) 9.8 (-1.3 to 20.9) 0.2 (-5.8 to 6.2) 4.1 (-7.4 to 15.7)
Midwest
SII (95%CI) -2.5 (-9.8 to 4.7) -2.3 (-7.9; 3.1) -3.9 (-10.9 to 3.0) -1.4 (-8.9 to 6.1)
CIX (95%CI) -4.8 (-12.4 to 2.8) -5.8 (-18.2 to 6.6) -4.5 (-12.1 to 3.1) -4.2 (-18.9 to 10.5)
Southeast
SII (95%CI) 0.6 (-5.4 to 6.7) 3.4 (-2.7 to 9.6) 3.2 (-2.3 to 8.7) 7.3 (1.0 to 13.6)
CIX (95%CI) 1.1 (-4.7 –6.9) 10.3 (-3.1 to 23.7) 3.4 (-2.2 to 9.1) 18.4 (5.8 to 31.0)
South
SII (95%CI) 4.0 (-10.9 to 2.8) 0 (-5.4 to 5.2) -9.9 (-15.7 to -4.0) 0.3 (-5.0 to 5.6)
CIX (95%CI) -7.4 (-13.6 to -1.1) 0.1 (-12.1 to 12.3) -10.6 (-16.4 to -4.7) 1.0 (-11.5 to 13.4)
Brazil
SII (95%CI) -0.89 (-4.1 to 234) 2.6 (-0.6 to 5.7) 1.4 (-1.6 to 4.4) 3.6 (0.3 to 7.0)
CIX (95%CI) -0.7 (-4.1 to 2.7) 7.81 (0.01 to 14.1) 1.4 (-2.0 to 4.8) 9.5 (2.0 to 17.1)
SII: absolute index of inequality; CIX: concentration index.
Bold figures represent statistically significant results. 
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men from the Southeast region with greater purchasing power (SII = 7.3 and CIX = 18.4) and 
among women from the South region with lower purchasing power (SII = -9.9 and CIX = -10.6). 
We also observed relative inequality among women with lower educational level. 
In addition, we conducted inequalities analyses to isolated chronic diseases (statistic 
association not described in the figure). We observed absolute and relative inequality in 
both genders, with a disease pattern mostly concentrated among individuals with higher 
purchasing power, finding high cholesterol levels (men), arthritis (women) and thyroid 
(both). We also observed thyroid disorders more concentrated (CIX) among men with higher 
educational level. As for arthritis, we also verified absolute and relative inequality among 
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women with higher educational level. We found that neurological disorders (men) were 
more concentrated (absolute and relative inequality) among those with lower educational 
level and, in relative manner, among those with lower purchasing power. We observed that 
digestive disorders (women) were most concentrated (absolute and relative inequality) 
among those with a lower educational level, in addition to a CIX with a health outcome 
concentrated among women with a lower purchasing power. To kidney disease, we observed 
a greater relative concentration among men with higher educational level and greater 
purchasing power. We found that cancer was most prevalent among women with lower 
educational levels (relative inequality) (Figure 2). 
DISCUSSION
The multimorbidity affected one in every ten Brazilian adults. When we extrapolate to the 
country’s population, this percentage represents nearly 11 million adults living in urban 
areas. In addition, we observed a greater prevalence of multimorbidity among women 
and older adults. We found social inequalities of low-magnitude (rates with significant 
difference, yet with values close to null) among men – relative inequality to educational 
level and absolute to socioeconomic class. 
DM: diabetes mellitus; HBP: high blood pressure; SII – absolute index of inequality; CIX = concentration index.
Note: Figures A and B – socioeconomic indicator = property ownership; Figures C and D – socioeconomic indicator = educational level. 
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When we compare the occurrence of multimorbidity found in this study (10.9%) with 
literature, we observe a difference of roughly 18 percentage points. A recent systematic 
review and meta-analysis19 also evidenced the occurrence of multimorbidity standardized 
by age affects 33.1% of the world population (adults and older adults); however, this rate 
varied across countries, being higher in those with higher incomes (37.9%) than in those 
countries with low and medium incomes (29.7%). In a cross-sectional study comprehending 
a sample of 28 countries with low and medium incomes, the multimorbidity was of 7.8%, 
presenting rates, respectively, of 3.8%, 12.8% and 21.3% to individuals aged between 18 to 
49, 50 to 64 and ≥ 65 years old 19. In Brazil, national and local studies with adults (≥18 years 
old) found prevalence rates varying from 20 to 50%4,5,8,9,12,20,21, having three of them finding 
prevalence rates around 30%. In addition to the already mentioned limitations, two reasons 
may justify the differences regarding the results of the present work: 1) differences in 
the type, in the measurement method and in the number of diseases considered in each 
study. For example, a study conducted in São Paulo (between May, 2005 and May, 2007) 
used validated and accurate questionnaires for the measurement of mental disorders, 
increasing the identification of ocurrences21; 2) national studies assessed the occurrence 
of multimorbidity in adults and older adults (≥ 60 years old), which tends to increase the 
average health outcome due to the higher occurrence among older adults. 
Regarding age, our findings evidenced increased multimorbidity among older adults, 
varying from 2.7% (95%CI 2.2–4.4) to 26.9% (95%CI 25.2–28.7) to adults aged 20 to 29 and 
50 to 59 years old, respectively. This association of multimorbidity with increased age 
is a common finding in studies, according to recent systemic review and metanalysis19. 
However, although the age increase translates into greater frequency of multiple concomitant 
disorders, we emphasize that, in absolute figures (SII), multimorbidity is most common in 
adults 22. This finding confirms the need of action by the healthcare systems and services 
to address the concomitant disorders in this age bracket of the population, including both 
the prevention of multimorbidity and the prevention of new diseases in these adults that 
already present multimorbidity. 
The present study also showed a prevalence of multimorbidity two times greater in women. 
A recent systematic revision and meta-analysis published on the subject19 corroborate 
these findings, in which 21 of the 25 selected articles reported a greater prevalence of 
multimorbidity in women. In addition, in one of the articles featured in this revision, the 
multimorbidity was nearly two times greater in women (74% in women, 24% in men).19 
The study by Afshar et al.23 also verified a higher occurrence of multimorbidity in the 
females in all countries considered in the study. A study4 observed similar results in 
national level, showing a prevalence of two or more chronic diseases among women of 
26.1% (95%CI 25.2–27.0) and of 17.5% (95%CI 16.6–18.3) among men. In addition, another 
study5 brought results regarding the multimorbidity prevalence, showing 35.2% (95%CI 
32.6–37.7) among women and 20.4% (95%CI 17.7–23.0) among men. A higher demand 
for healthcare services24 may explain the higher prevalence of multimorbidity among 
women, with a greater exposition to diagnosis, as per the findings of a study carried 
out in the United States25, in which women aged between 18 and 64 years old were most 
likely to present multiple chronic disorders. In addition, men has a lower life expectancy 
and, therefore, a lower tendency to develop long-term health problems26. Thus, women, 
as they live longer, as more exposed throughout life to stressful events that compromise 
the physiopathological balance and favor the emerging of diseases.27 
We observed an association between multimorbidity and socioeconomic indicators 
only among men with higher purchasing power, when we assessed the absolute (SII) 
and the relative (CIX) inequality indexes, and among men with higher educational 
level, considering the relative inequality index (CIX). Despite the different measurement 
methods described in the literature, these results are in line with published evidence 
regarding such association2,10,22, including the national studies on educational levels4,5,8, 
whose results show inverse association between these indicators and the prevalence of 
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morbidity. A study conducted by Afshar et al.23, in 28 low- and medium-income countries, 
found a positive relation, although not linear, between the country’s gross domestic 
product and the prevalence of multimorbidity. Regarding the educational level, higher 
education was significantly associated with the reduction of the multimorbidity risk in 
the analyses of all regions. 
The way the questionnaire was applied to the participants may explain the findings of this 
study, inquiring about the medical diagnosis regarding the assessed morbidities. It refers to 
individuals that, in theory, received medical attention and, thus, accessed to the diagnosis. 
In this sense, a differential error may exist in the assessed association: people with a higher 
purchasing power are more likely to access healthcare services and, consequently, get 
morbidities diagnosis. Thus, possibly, the prevalence of multimorbidity was higher among 
individuals with higher purchasing power (wealthier socioeconomic classes and higher 
educational level28. Yet, the analyses ran for isolated diseases evidenced inequalities, both 
for individuals with a higher purchasing power (high cholesterol levels, arthritis and thyroid 
disorders, other diseases) and for those with a lower purchasing power (digestive disorder) 
and lower educational level (neurological and digestive disorders and cancer), unlike the 
findings by Jantsch et al12, in which the morbidities, in general, were most prevalent among 
individuals with low educational level. 
In the cross-sectional study aforementioned12, conducted in Rio de Janeiro, the 
association between education level and multimorbidity was different according to 
gender. Women who had not finished elementary school presented more than twice 
occurrences of multimorbidity than those who had finished postgrad. However, among 
men, the multimorbidity was lower among those who had finished and not finished the 
elementary school, but this result was not statistically significant. In the calculation of 
the SII, the study observed that women with a lower educational level presented 22% 
more multimorbidity than those with higher educational levels. In relative terms, using 
the CIX, the study found a morbidity three times higher in lower educational levels, with 
a greater inequality level among women12. 
The systematic review and the meta-analysis published by Pathirana et al.13, with the aim 
to assess this evaluation, showed heterogeneous methods of measuring the socioeconomic 
level. The review verified that a low educational level was associated with a 64% increased 
chance of multimorbidity occurrence. However, when aggregating these studies by age, 
the association is higher in the older populations. This fact may explain why we did not 
find such association in this study, given that the focus were adults aged between 20 and 
59 years old. 
We verified socioeconomic inequalities for certain diseases in Isolation. Although 
presenting a list of diseases slightly different than those adopted in this work, Jantsch 
et at.12 found that all conditions (hypertension, diabetes, dyslipidemia, coronary 
heart disease, stroke, chronic pulmonary disease, peptic ulcer disease, cholecystitis, 
osteomuscular disorder and thyroid disorder), except repetitive strain injury, showed a 
significant linear trend among women, more prevalent among those with low educational 
levels. Among men, the association was statistically significant only for hypertension, 
diabetes, coronary heart disease, repetitive strain injury and peptic ulcer disease. The 
low rate of prevalence of certain disorders in this group may also explain the lack of 
association among men, such as thyroid disorders and cancer.
To enable a better comprehension of this finding, certain limitations must be emphasized. 
First, the limited number of chronic diseases considered in the study may underestimate the 
occurrence of concomitant morbidities, reducing the percentage of individuals presenting 
multimorbidity. Even though the questionnaire listed a question inquiring about another 
chronic disease, the interviewee may have failed to mention another existing disease, 
once that the question was not specific about the morbidities – which would rely on the 
interviewee’s memory. Second, the information about the presence of a chronic disease was 
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based in the self-reported medical diagnosis, being this an usual method in epidemiological 
studies, but with limited accuracy29, even for prevalent conditions21,4. Third, the lack of 
standards in the definition of the problem hampers the definition of multimorbidity cases 
and the comparison between studies30. 
The results show, in general, socioeconomic equality in the occurrence of multimorbidity, 
measured by the medical diagnosis of diseases. The low association found is a result 
discrepant from existing literature on the subject and demands further analyses able 
to support the health public policies regarding to inequalities. It is also noteworthy the 
importance of using these indexes in the inequality analyses, given that they consider the 
entire sample distribution of the indicator, and not only end values of it, as it is the case in 
raw analyses of income and educational levels15. 
Nevertheless, the relative frequency and, mostly, the absolute frequency of multimorbidity, 
in this own, emphasize the relevance of multimorbidity among Brazilian adults, especially 
among women. With the trend of emergence of multimorbidity in earlier stages of life, there 
is an increase in the odds of an individual seek for healthcare services (especially emergency 
and hospitalization services), of premature death and worse quality of life. Therefore, it is 
important to direct public policies to serve this parcel of the population, who is getting 
sick increasingly early. 
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